Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels
スポンサーリンク
概要
- 論文の詳細を見る
Background: In hemodialysis patients, adynamic bone disease has been reported to be closely associated with low levels of parathyroid hormone (PTH) due to exposure to high levels of serum calcium following the administration of calcium carbonate (CaCO3) or vitamin D agents. This study was conducted to clarify the therapeutic effect of a non-calcemic phosphate binder, sevelamer hydrochloride (sevelamer), for hypoparathyroidism in hemodialysis patients with or without diabetes mellitus. Methods: Based on entry criteria, 40 Japanese chronic hemodialysis patients (22 males and 18 females with a mean age of 60.6, 14 diabetic patients and 26 non-diabetic patients) were switched from CaCO3 to sevelamer for 48 weeks. Serum calcium, phosphate, intact (i) PTH and PTH-(1-84) were analyzed. Bone remodeling activity was evaluated by determining intact osteocalcine (iOC), bone-specific alkaline phosphatase (BAP). Results: The switch from CaCO3 to sevelamer significantly decreased the serum levels of calcium, resulting in the elevation of iPTH levels from 31±18 pg/mL to 95±96 pg/mL by 48 weeks. In contrast, serum phosphate levels remained similar to those in patients with CaCO3 treatment. Concomitantly, the levels of BAP and iOC were elevated. Further, these beneficial effects on bone turnover were observed in both diabetic and non-diabetic patients. Conclusion: Sevelamer reduced the calcium concentration and thereby increased PTH levels, resulting in the improvement of markers of bone turnover. The administration of sevelamer is of therapeutic benefit for the improvement of bone remodeling activity even in hemodialysis patients with diabetes. © 2007 The Japanese Society of Internal Medicine.
- 日本内科学会の論文
著者
-
YOKOYAMA Hitoshi
Department of Gastroenterology and Nephrology, Kanazawa University Graduate School of Medical Scienc
-
Wada Takashi
金沢大学 医学部血液浄化療法部
-
Iwata Yasunori
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Wada Takashi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Toyama Tadashi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Kitajima Shinji
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Okumura Toshiya
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Hara Akinori
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Yamahana Junya
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Nakaya Izaya
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Kobayashi Motoo
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Kitagawa Kiyoki
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Kokubo Satoshi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Yoshimoto Keiichi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Shimizu Kazuaki
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Sakai Norihiko
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Furuichi Kengo
Division of Blood Purification, Kanazawa University Hospital
-
Koshino Yoshitaka
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Takaeda Chikako
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Takeda Shinichi
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Takasawa Kazuya
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Ohta Satoshi
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Takaeda Masayoshi
The Kanazawa Study Group for Renal Diseases and Hypertension
-
Kaneko Shuichi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medicine
-
Toyama Tadashi
富山県立中央病院 内科
-
Nakaya Izaya
富山県立中央病院 内科
-
Yokoyama Hitoshi
Department Of Cardiovascular Surgery Faculty Of Medicine Fukushima Medical University
-
Furuichi Kengo
Division Of Blood Purification Department Of Gastroenterology And Nephrology Graduate School Of Medi
-
Kaneko Shuichi
Disease Control And Homeostasis Graduate School Of Medical Science Kanazawa University
関連論文
- DP-134-4 胃癌におけるSonic hedgehog pathwayの活性化の臨床病理学的検討(第108回日本外科学会定期学術集会)
- S3-3. 早期胃癌手術例における幽門保存胃切除術有用性(第36回胃外科・術後障害研究会)
- P-2-485 大腸SM癌に対する至適リンパ節郭清範囲の検討(大腸・肛門 危険因子・予後1,一般演題(ポスター),第62回日本消化器外科学会定期学術総会)
- P-2-43 食道癌のSN手術におけるMDCTとSPECTによる三次元画像合成の有用性の検討(食道癌 画像診断,鏡視下手術,一般演題(ポスター),第62回日本消化器外科学会定期学術総会)
- V-2-22 食道癌,下咽頭癌手術における血行再建の工夫と合併症予防(食道2 血管吻合/その他,一般演題(ビデオ),第62回日本消化器外科学会定期学術総会)
- V-1-1 胃癌リンパ節郭清における超音波凝固切開装置の有用性(胃1 手技・器機1,一般演題(ビデオ),第62回日本消化器外科学会定期学術総会)
- SP-21 ダブルバルーン内視鏡にて診断され外科的治療となった小腸疾患の2例(特別ポスター3 小腸・出血,第62回日本消化器外科学会定期学術総会)
- ORNITHINE DECARBOXYLASE ACTIVITY AS A PROGNOSTIC MARKER FOR COLORECTAL CANCER
- DP-150-4 腹腔鏡下大腸癌手術の治療成績(第107回日本外科学会定期学術集会)
- DP-136-4 食道癌のセンチネルリンパグラフィーにおけるSingle Photon Emission Computed Tomography(SPECT)とMulti-detector raw Computed Tomography(MDCT)による三次元画像合成法の検討(第107回日本外科学会定期学術集会)